Conversely, SEMA6D was overexpressed in both age groups’ T1D-1/2 subgroups, however, insulin treatment cannot effectively reduce its protein expression levels to a degree similar to the Con-l/2 subgroup. This evidence concerns the gene INS and type 1 diabetes mellitus.